Irinotecan for Pediatric Solid Tumors: The Memorial Sloan-Kettering Experience-Reference-Cited by-同舟云学术

Irinotecan for Pediatric Solid Tumors: The Memorial Sloan-Kettering Experience

Published:2002-02 Issue:2 Volume:24 Page:101-105
ISSN:0192-8562
Container-title:Journal of Pediatric Hematology/Oncology
language:en
Short-container-title:Journal of Pediatric Hematology/Oncology

Author:

Cosetti Maura,Wexler Leonard H.,Calleja Elizabeth,Trippett Tanya,LaQuaglia Michael,Huvos Andrew G.,Gerald William,Healey John H.,Meyers Paul A.,Gorlick Richard

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference19 articles.

1. The Current Status of Camptothecin Analogues as Antitumor Agents

2. Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors

3. Evaluation of 9-dimethylaminomethyl-10-hydroxycamptothecin against xenografts derived from adult and childhood solid tumors

4. Phase I Study of a Weekly Schedule of Irinotecan, High-Dose Leucovorin, and Infusional Fluorouracil as First-Line Chemotherapy in Patients With Advanced Colorectal Cancer

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of vincristine, irinotecan and anlotinib in Epithelioid Sarcoma;BMC Cancer;2024-02-03

2. The Future of HER2-Targeted Treatment for Osteosarcoma: Lessons from the Negative Trastuzumab Deruxtecan Results;International Journal of Molecular Sciences;2023-11-27

3. A potential alternative systemic treatment option for epithelioid sarcoma;2022-12-22

4. Prognostic value of patient‐derived xenograft engraftment in pediatric sarcomas;The Journal of Pathology: Clinical Research;2021-04-09

5. Anlotinib, Vincristine, and Irinotecan for Advanced Ewing Sarcoma After Failure of Standard Multimodal Therapy: A Two-Cohort, Phase Ib/II Trial;The Oncologist;2021-03-08